The tumor promoting roles of HSP60 and HIF2α in gastric cancer cells

Heat Shock Proteins as Prognostic Markers of Cancer

(2014) Evgeniya Kaigorodova et al.   CURRENT CANCER DRUG TARGETS

HIF-2α as a prognostic marker for breast cancer progression and patient survival

(2014) H.X. Wang et al.   GENETICS AND MOLECULAR RESEARCH

HSP60 Predicts Survival in Advanced Serous Ovarian Cancer

(2013) Elisabet Hjerpe et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

BRG1 and BRM Chromatin-Remodeling Complexes Regulate the Hypoxia Response by Acting as Coactivators for a Subset of Hypoxia-Inducible Transcription Factor Target Genes

(2013) J. A. Sena et al.   MOLECULAR AND CELLULAR BIOLOGY

The anti-tumor role and mechanism of integrated and truncated PDCD5 proteins in osteosarcoma cells

(2012) Xiao-Rui Han et al.   CELLULAR SIGNALLING

COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin

(2011) Michelle D. Holmes et al.   BREAST CANCER RESEARCH AND TREATMENT

Identification and verification of heat shock protein 60 as a potential serum marker for colorectal cancer

(2011) Céline Hamelin et al.   FEBS Journal

Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies

(2011) Shinji Tanaka et al.   JOURNAL OF GASTROENTEROLOGY

Heat shock protein-60 expression was significantly correlated with the prognosis of lung adenocarcinoma

(2011) Xin Xu et al.   JOURNAL OF SURGICAL ONCOLOGY

Heat shock proteins in ovarian cancer: A potential target for therapy

(2010) Marie Cohen et al.   GYNECOLOGIC ONCOLOGY

Heat shock proteins 27, 60 and 70 as prognostic markers of prostate cancer 

(2008) AXEL GLAESSGEN et al.   APMIS